CSF presenilin-1 complexes are increased in Alzheimer's disease

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  García Ayllón, María Salud ^a,b,c   Campanari, María Letizia ^a,b   Brinkmalm, Gunnar ^d   Rábano, Alberto ^b,e   Alom, Jordi ^b,c   Saura, Carlos A ^b,f   Andreasen, Niels ^g   Blennow, Kaj ^d   Sáez Valero, Javier ^a,b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e Instituto de Salud Carlos III   (Spain)

^f INSTITUT DE NEUROCIÈNCIES   (Spain)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Biomarker; Cerebrospinal fluid; Diagnostic; Presenilin 1

Indexed keywords

APH1A PROTEIN, HUMAN; ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BIOLOGICAL MARKER; MEMBRANE PROTEIN; PEPTIDE HYDROLASE; PRESENILIN 1; PRESENILIN 1, MOUSE; PSEN1 PROTEIN, HUMAN; PSENEN PROTEIN, HUMAN; SECRETASE;

AGED; ALZHEIMER DISEASE; ANIMAL; BLOOD; C57BL MOUSE; CEREBROSPINAL FLUID; FEMALE; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; LUMBAR VERTEBRA; MALE; MIDDLE AGED;

AGED; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUMBAR VERTEBRAE; MALE; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PEPTIDE HYDROLASES; PRESENILIN-1;

EID: 85005925769     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/20515960146     Document Type: Article

References (55)

1. Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. Lancet 2006, 368: 387-403. 10.1016/S0140-6736(06)69113-7
2. Thinakaran G, Koo EH: Amyloid precursor protein trafficking, processing, and function. J Biol Chem 2008, 283: 29615-29619. 10.1074/jbc.R800019200
3. Vassar R, Kovacs DM, Yan R, Wong PC: The beta-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 2009, 29: 12787-12794. 10.1523/JNEUROSCI.3657-09.2009
4. Holsinger RM, McLean CA, Collins SJ, Masters CL, Evin G: Increased beta-Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects. Ann Neurol 2004, 55: 898-899. 10.1002/ana.20144
5. Kaether C, Haass C, Steiner H: Assembly, trafficking and function of gamma-secretase. Neurodegener Dis 2006, 3: 275-283. 10.1159/000095267
6. Laudon H, Hansson EM, Melén K, Bergman A, Farmery MR, Winblad B, Lendahl U, von Heijne G, Näslund J: A nine-transmembrane domain topology for presenilin 1. J Biol Chem 2005, 280: 35352-35360. 10.1074/jbc.M507217200
7. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, Levesque L, Rogaeva E, Xu D, Liang Y, Duthie M, St George-Hyslop PH, Fraser PE: The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J Biol Chem 1998, 273: 16470-16475. 10.1074/jbc.273.26.16470
8. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey AI, Gandy SE, Jenkins NA, Copeland NG, Price DL, Sisodia SS: Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 1996, 17: 181-190. 10.1016/S0896-6273(00)80291-3
9. Podlisny MB, Citron M, Amarante P, Sherrington R, Xia W, Zhang J, Diehl T, Levesque G, Fraser P, Haass C, Koo EH, Seubert P, St George-Hyslop P, Teplow DB, Selkoe DJ: Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis 1997, 3: 325-337. 10.1006/nbdi.1997.0129
10. Capell A, Grünberg J, Pesold B, Diehlmann A, Citron M, Nixon R, Beyreuther K, Selkoe DJ, Haass C: The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 1998, 273: 3205-3211. 10.1074/jbc.273.6.3205
11. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, Felsenstein KM, Hyman BT, Tanzi RE, Wasco W: Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 1996, 2: 224-229. 10.1038/nm0296-224
12. De Strooper B, Beullens M, Contreras B, Levesque L, Craessaerts K, Cordell B, Moechars D, Bollen M, Fraser P, George-Hyslop PS, Van Leuven F: Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J Biol Chem 1997, 272: 3590-3598. 10.1074/jbc.272.6.3590
13. Silveyra MX, Evin G, Montenegro MF, Vidal CJ, Martínez S, Culvenor JG, Sáez-Valero J: Presenilin-1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation. Mol Cell Biol 2008, 28: 2908-2919. 10.1128/MCB.02065-07
14. Nyabi O, Bentahir M, Horré K, Herreman A, Gottardi-Littell N, Van Broeckhoven C, Merchiers P, Spittaels K, Annaert W, De Strooper B: Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 2003, 278: 43430-43436. 10.1074/jbc.M306957200
15. Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS, Selkoe DJ: Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci USA 2003, 100: 6382-6387. 10.1073/pnas.1037392100
16. Edbauer D, Winkler E, Haass C, Steiner H: Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc Natl Acad Sci USA 2002, 99: 8666-8671.
17. Farmery MR, Tjernberg LO, Pursglove SE, Bergman A, Winblad B, Näslund J: Partial purification and characterization of gamma-secretase from post-mortem human brain. J Biol Chem 2003, 278: 24277-24284. 10.1074/jbc.M211992200
18. Saura CA, Servián-Morilla E, Scholl FG: Presenilin/γ-secretase regulates neurexin processing at synapses. PLoS One 2011, 6: e19430. 10.1371/journal.pone.0019430
19. Zhong Z, Ewers M, Teipel S, Bürger K, Wallin A, Blennow K, He P, McAllister C, Hampel H, Shen Y: Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psychiatry 2007, 64: 718-726. 10.1001/archpsyc.64.6.718
20. Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, Simon AJ, Blennow K: Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol 2008, 65: 1102-1107. 10.1001/archneur.65.8.1102
21. Mulder SD, van der Flier WM, Verheijen JH, Mulder C, Scheltens P, Blankenstein MA, Hack CE, Veerhuis R: BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology. J Alzheimers Dis 2010, 20: 253-260.
22. Verheijen JH, Huisman LG, van Lent N, Neumann U, Paganetti P, Hack CE, Bouwman F, Lindeman J, Bollen EL, Hanemaaijer R: Detection of a soluble form of BACE-1 in human cerebrospinal fluid by a sensitive activity assay. Clin Chem 2006, 52: 1168-1174. 10.1373/clinchem.2006.066720
23. Benussi L, Alberici A, Mayhaus M, Langer U, Ghidoni R, Mazzoli F, Nicosia F, Barbiero L, Frisoni G, Zanetti O, Gasparini L, Nitsch RM, Binetti G: Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosis. Exp Cell Res 2001, 269: 256-265. 10.1006/excr.2001.5329
24. Yamamoto A, Sahara N, Usami M, Okochi M, Kondo T, Kametani F, Tanaka K, Yahagi Y, Shirasawa T, Itoyama Y, Mori H: Abnormal gel-electrophoretic behavior of presenilin 1 and it's fragment. Biochem Biophys Res Commun 1996, 226: 536-541. 10.1006/bbrc.1996.1390
25. Busciglio J, Hartmann H, Lorenzo A, Wong C, Baumann K, Sommer B, Staufenbiel M, Yankner BA: Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J Neurosci 1997, 17: 5101-5107.
26. Chyung JH, Raper DM, Selkoe DJ: Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage. J Biol Chem 2005, 280: 4383-4392.
27. Sato T, Diehl TS, Narayanan S, Funamoto S, Ihara Y, De Strooper B, Steiner H, Haass C, Wolfe MS: Active gamma-secretase complexes contain only one of each component. J Biol Chem 2007, 282: 33985-33993. 10.1074/jbc.M705248200
28. Hébert SS, Godin C, Lévesque G: Oligomerization of human presenilin-1 fragments. FEBS Lett 2003, 550: 30-34. 10.1016/S0014-5793(03)00813-5
29. Wolfe MS: Gamma-Secretase inhibitors as molecular probes of presenilin function. J Mol Neurosci 2001, 17: 199-204. 10.1385/JMN:17:2:199
30. Chung HM, Struhl G: Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. Nat Cell Biol 2001, 3: 1129-1132. 10.1038/ncb1201-1129
31. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C: Reconstitution of gamma-secretase activity. Nat Cell Biol 2003, 5: 486-488. 10.1038/ncb960
32. Saura CA, Tomita T, Davenport F, Harris CL, Iwatsubo T, Thinakaran G: Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing. J Biol Chem 1999, 274: 13818-13823. 10.1074/jbc.274.20.13818
33. Barão S, Zhou L, Adamczuk K, Vanhoutvin T, van Leuven F, Demedts D, Vijverman AC, Vijverman AC, Bossuyt X, Vandenberghe R, De Strooper B: BACE1 Levels Correlate With Phospho-Tau Levels In Human Cerebrospinal Fluid. Curr Alzheimer Res 2013. Apr 8. [Epub ahead of print]
34. Borghi R, Piccini A, Barini E, Cirmena G, Guglielmotto M, Tamagno E, Fornaro M, Perry G, Smith MA, Garuti A, Tabaton M: Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease. J Alzheimers Dis 2010, 22: 771-775.
35. Kakuda N, Shoji M, Arai H, Furukawa K, Ikeuchi T, Akazawa K, Takami M, Hatsuta H, Murayama S, Hashimoto Y, Miyajima M, Arai H, Nagashima Y, Yamaguchi H, Kuwano R, Nagaike K, Ihara Y: Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease. EMBO Mol Med 2012, 4: 344-352. 10.1002/emmm.201200214
36. Mathews PM, Cataldo AM, Kao BH, Rudnicki AG, Qin X, Yang JL, Jiang Y, Picciano M, Hulette C, Lippa CF, Bird TD, Nochlin D, Walter J, Haass C, Lévesque L, Fraser PE, Andreadis A, Nixon RA: Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease. Mol Med 2000, 6: 878-891.
37. Davidsson P, Bogdanovic N, Lannfelt L, Blennow K: Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease. Dement Geriatr Cogn Disord 2001, 12: 243-250. 10.1159/000051266
38. Verdile G, Gnjec A, Miklossy J, Fonte J, Veurink G, Bates K, Kakulas B, Mehta PD, Milward EA, Tan N, Lareu R, Lim D, Dharmarajan A, Martins RN: Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology 2004, 63: 1385-1392. 10.1212/01.WNL.0000141848.45315.A6
39. Johnston JA, Froelich S, Lannfelt L, Cowburn RF: Quantification of presenilin-1 mRNA in Alzheimer's disease brains. FEBS Lett 1996, 394: 279-284. 10.1016/0014-5793(96)00969-6
40. Ikeda K, Urakami K, Arai H, Wada K, Wakutani Y, Ji Y, Adachi Y, Okada A, Kowa H, Sasaki H, Ohno K, Ohtsuka Y, Ishikawa Y, Nakashima K: The expression of presenilin 1 mRNA in skin fibroblasts and brains from sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2000, 11: 245-250. 10.1159/000017246
41. Silveyra MX, García-Ayllón MS, Serra-Basante C, Mazzoni V, García-Gutierrez MS, Manzanares J, Culvenor JG, Sáez-Valero J: Changes in acetylcholinesterase expression are associated with altered presenilin-1 levels. Neurobiol Aging 2012, 33: 627.e27-37.
42. Lee MK, Slunt HH, Martin LJ, Thinakaran G, Kim G, Gandy SE, Seeger M, Koo E, Price DL, Sisodia SS: Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 1996, 16: 7513-7525.
43. Nilsberth C, Luthman J, Lannfelt L, Schultzberg M: Expression of presenilin 1 mRNA in rat peripheral organs and brain. Histochem J 1999, 31: 515-523. 10.1023/A:1003887922777
44. Blennow K: Biomarkers in Alzheimer's disease drug development. Nat Med 2010, 16: 1218-1222. 10.1038/nm.2221
45. Blennow K, Hampel H: CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003, 2: 605-613. 10.1016/S1474-4422(03)00530-1
46. Selkoe DJ, Wolfe MS: Presenilin: running with scissors in the membrane. Cell 2007, 131: 215-221. 10.1016/j.cell.2007.10.012
47. Bergmans BA, De Strooper B: Gamma-secretases: from cell biology to therapeutic strategies. Lancet Neurol 2010, 9: 215-226. 10.1016/S1474-4422(09)70332-1
48. Mirra SS, Gearing M, McKeel DW Jr, Crain BJ, Hughes JP, van Belle G, Heyman A: Interlaboratory comparison neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry of Alzheimer's Disease (CERAD). J Neuropath Exp Neurol 1994, 53: 303-315. 10.1097/00005072-199405000-00012
49. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34: 939-944. 10.1212/WNL.34.7.939
50. Yu H, Saura CA, Choi SY, Sun LD, Yang X, Handler M, Kawarabayashi T, Younkin L, Fedeles B, Wilson MA, Younkin S, Kandel ER, Kirkwood A, Shen J: APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron 2001, 31: 713-726. 10.1016/S0896-6273(01)00417-2
51. Sáez-Valero J, de Gracia JA, Lockridge O: Intraperitoneal administration of 340 kDa human plasma butyrylcholinesterase increases the level of the enzyme in the cerebrospinal fluid of rats. Neurosci Lett 2005, 383: 93-98. 10.1016/j.neulet.2005.03.045
52. Culvenor JG, Maher F, Evin G, Malchiodi-Albedi F, Cappai R, Underwood JR, Davis JB, Karran EH, Roberts GW, Beyreuther K, Masters CL: Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment. J Neurosci Res 1997, 49: 719-731. 10.1002/(SICI)1097-4547(19970915)49:6<719::AID-JNR6>3.0.CO;2-A
53. Schägger H, von Jagow G: Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 1991, 199: 223-231. 10.1016/0003-2697(91)90094-A
54. Evin G, Sharples RA, Weidemann A, Reinhard FB, Carbone V, Culvenor JG, Holsinger RM, Sernee MF, Beyreuther K, Masters CL: Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease. Biochemistry 2001, 40: 8359-8368. 10.1021/bi002770t
55. Culvenor JG, Ilaya NT, Ryan MT, Canterford L, Hoke DE, Williamson NA, McLean CA, Masters CL, Evin G: Characterization of presenilin complexes from mouse and human brain using Blue Native gel electrophoresis reveals high expression in embryonic brain and minimal change in complex mobility with pathogenic presenilin mutations. Eur J Biochem 2004, 271: 375-385. 10.1046/j.1432-1033.2003.03936.x